Loading…
Radiotherapy for extensive stage small-cell lung cancer – Authors' reply
Of 495 patients included in the ITT analysis, 434 had residual intrathoracic disease at baseline (of whom 215 were allocated to the thoracic radiotherapy group and 219 to the control group), and 61 patients had no residual intrathoracic disease (of whom 32 were allocated to the thoracic radiotherapy...
Saved in:
Published in: | The Lancet (British edition) 2015-04, Vol.385 (9975), p.1292-1293 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Of 495 patients included in the ITT analysis, 434 had residual intrathoracic disease at baseline (of whom 215 were allocated to the thoracic radiotherapy group and 219 to the control group), and 61 patients had no residual intrathoracic disease (of whom 32 were allocated to the thoracic radiotherapy group and 29 to the control group). Since residual intrathoracic disease was a stratification factor, we found no differences in patient characteristics between the two groups. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(15)60679-1 |